| scholarly article | Q13442814 |
| P50 | author | Peter Buchwald | Q39967319 |
| Klaas J. Wierenga | Q120869563 | ||
| P2093 | author name string | Kent Lai | |
| Manshu Tang | |||
| P2860 | cites work | Functional analysis of disease‐causing mutations in human galactokinase | Q24299794 |
| Structure and mechanism of homoserine kinase: prototype for the GHMP kinase superfamily | Q27629750 | ||
| ENZYMATIC EXPRESSION AND GENETIC LINKAGE OF GENES CONTROLLING GALACTOSE UTILIZATION IN SACCHAROMYCES. | Q27932052 | ||
| A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays | Q28145712 | ||
| Congenital galactosemia, a single enzymatic block in galactose metabolism | Q28212638 | ||
| Virtual screening of chemical libraries | Q33209939 | ||
| Galactokinase: structure, function and role in type II galactosemia | Q33982846 | ||
| Molecular structure of human galactokinase: implications for type II galactosemia | Q33983696 | ||
| The enzymatic transformation of uridine diphosphate glucose into a galactose derivative | Q34297292 | ||
| Galactose-1-phosphate in the pathophysiology of galactosemia | Q34721308 | ||
| Clinical features of galactokinase deficiency:A review of the literature | Q35111155 | ||
| High tolerance for oral galactose in classical galactosaemia: dietary implications. | Q35277656 | ||
| ChemBank: a small-molecule screening and cheminformatics resource database | Q36454111 | ||
| Newborn screening fact sheets | Q36584844 | ||
| Additional findings in galactokinase deficiency | Q39957829 | ||
| Hidden sources of galactose in the environment. | Q40480941 | ||
| GALT deficiency causes UDP-hexose deficit in human galactosemic cells | Q40665629 | ||
| Regulation of genes controlling synthesis of the galactose pathway enzymes in yeast. | Q41821687 | ||
| The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency | Q42558448 | ||
| Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast | Q43612292 | ||
| The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency | Q44732112 | ||
| Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model | Q46708765 | ||
| Determining appropriate substrate conversion for enzymatic assays in high-throughput screening | Q47278992 | ||
| Estimation of galactose-1-phosphate in erythrocytes: A rapid and simple enzymatic method | Q51685498 | ||
| Long‐term prognosis in galactosaemia: Results of a survey of 350 cases | Q52243798 | ||
| Yeast as a screening tool. | Q53668666 | ||
| Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia | Q63644737 | ||
| Galactose metabolism in a patient with hereditary galactokinase deficiency | Q68686360 | ||
| Galactosemia: how does long-term treatment change the outcome? | Q70617007 | ||
| Galactitol and galactose-1-phosphate in the lens of a galactosemic infant | Q72207756 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 415-423 | |
| P577 | publication date | 2008-05-19 | |
| P1433 | published in | Journal of Biomolecular Screening | Q6294856 |
| P1476 | title | High-throughput screening for human galactokinase inhibitors | |
| P478 | volume | 13 |
| Q91927626 | Discovery of novel inhibitors of human galactokinase by virtual screening |
| Q38234643 | GALK inhibitors for classic galactosemia |
| Q33669582 | Galactose and its Metabolites Deteriorate Metaphase II Mouse Oocyte Quality and Subsequent Embryo Development by Disrupting the Spindle Structure |
| Q24646350 | Galactose toxicity in animals |
| Q34014282 | Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) kinase of Gram-negative bacteria |
| Q54357270 | Increased promiscuity of human galactokinase following alteration of a single amino acid residue distant from the active site. |
| Q34054239 | Innovative therapy for Classic Galactosemia - tale of two HTS. |
| Q63644723 | Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia |
| Q28483059 | IspE inhibitors identified by a combination of in silico and in vitro high-throughput screening |
| Q43252785 | Mechanistic studies on human N-acetylgalactosamine kinase |
| Q24607116 | Molecular and biochemical characterization of human galactokinase and its small molecule inhibitors |
| Q90661175 | Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia |
| Q34714428 | Ovarian function in girls and women with GALT-deficiency galactosemia |
| Q36486013 | Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia |
| Q43286013 | Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction |
| Q35572971 | Structure-activity analysis and cell-based optimization of human galactokinase inhibitors |
| Q33563888 | Sweet and sour: an update on classic galactosemia. |
| Q61800932 | The Distribution of Standard Deviations Applied to High Throughput Screening |
| Q45776629 | The hazardous effects of three natural food dyes on developmental stages and longevity of Drosophila melanogaster |
| Q37906514 | The structural and molecular biology of type I galactosemia: Enzymology of galactose 1-phosphate uridylyltransferase |
Search more.